ComplianceOnline

Oral Dosage Form New Animal Drugs;Toceranib

  • Date: November 02, 2009
  • Source: www.fda.gov
Webinar All Access Pass Subscription Abstract:

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the original approval of a new animal drug application (NADA) filed by Pharmacia & Upjohn Co., a Division of Pfizer, Inc. The NADA provides for the veterinary prescription use of toceranib phosphate tablets in dogs for treatment of recurrent, cutaneous mast cell tumors .

Effective Date: This rule is effective June 18,2009

Bookmark and Share
Best Sellers
You Recently Viewed
    Loading